288 related articles for article (PubMed ID: 30167573)
21. Primary Autologous Stem Cell Transplantation for Unilateral Primary Central Nervous System Lymphoma-Ophthalmic Variant (Primary Vitreoretinal Lymphoma).
Lee B; de Vos S; McCannel CA
J Vitreoretin Dis; 2023; 7(6):548-551. PubMed ID: 38022793
[No Abstract] [Full Text] [Related]
22. Clinical Features of Primary Vitreoretinal Lymphoma: A Single-center Study.
Kase S; Namba K; Iwata D; Mizuuchi K; Ito T; Hase K; Suzuki K; Onozawa M; Kitaichi N; Ishida S
Cancer Diagn Progn; 2021; 1(2):69-75. PubMed ID: 35403133
[TBL] [Abstract][Full Text] [Related]
23. CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential.
Yonese I; Takase H; Yoshimori M; Onozawa E; Tsuzura A; Miki T; Mochizuki M; Miura O; Arai A
Eur J Haematol; 2019 Feb; 102(2):191-196. PubMed ID: 30390359
[TBL] [Abstract][Full Text] [Related]
24. Primary vitreoretinal lymphomas display a remarkably restricted immunoglobulin gene repertoire.
Belhouachi N; Xochelli A; Boudjoghra M; Lesty C; Cassoux N; Fardeau C; Tran THC; Choquet S; Sarker B; Houillier C; Alentorn A; LeHoang P; Soussain C; Touitou V; Merle-Beral H; Hoang-Xuan K; Bodaghi B; Stamatopoulos K; Davi F
Blood Adv; 2020 Apr; 4(7):1357-1366. PubMed ID: 32267931
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic methods for primary vitreoretinal lymphoma: A systematic review.
Huang RS; Mihalache A; Popovic MM; Cruz-Pimentel M; Pandya BU; Muni RH; Kertes PJ
Surv Ophthalmol; 2024; 69(3):456-464. PubMed ID: 38163550
[TBL] [Abstract][Full Text] [Related]
26. Primary Vitreoretinal Lymphoma: Current Diagnostic Laboratory Tests and New Emerging Molecular Tools.
Melli B; Gentile P; Nicoli D; Farnetti E; Croci S; Gozzi F; Bolletta E; De Simone L; Sanguedolce F; Palicelli A; Zizzo M; Ricci S; Ilariucci F; Rossi C; Cavazza A; Ascani S; Cimino L; Zanelli M
Curr Oncol; 2022 Sep; 29(10):6908-6921. PubMed ID: 36290820
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal observation of OCT imaging is a valuable tool to monitor primary vitreoretinal lymphoma treated with intravitreal injections of methotrexate.
Zhao H; Wang X; Mao Y; Peng X
BMC Ophthalmol; 2020 Jan; 20(1):10. PubMed ID: 31906917
[TBL] [Abstract][Full Text] [Related]
28. An unusual case report of primary vitreoretinal lymphoma.
Tan SZ; Steeples LR; Chhabra R; Jones NP
BMC Ophthalmol; 2018 Sep; 18(Suppl 1):223. PubMed ID: 30255824
[TBL] [Abstract][Full Text] [Related]
29. [Molecular diagnostics for vitreoretinal lymphoma].
Bonzheim I; Salmerón-Villalobos J; Süsskind D; Szurman P; Gekeler F; Spitzer MS; Salaverria I; Campo E; Coupland SE; Quintanilla-Martinez L; Fend F
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):150-154. PubMed ID: 37947807
[TBL] [Abstract][Full Text] [Related]
30. Primary vitreoretinal lymphoma.
Mulay K; Narula R; Honavar SG
Indian J Ophthalmol; 2015 Mar; 63(3):180-6. PubMed ID: 25971162
[TBL] [Abstract][Full Text] [Related]
31. Histopathologic Diagnosis of Atypical Primary Vitreoretinal Lymphoma following Enucleation.
Sood AB; Yeh S; Mendoza P; Grossniklaus HE
Ocul Oncol Pathol; 2016 Oct; 2(4):242-245. PubMed ID: 27843904
[TBL] [Abstract][Full Text] [Related]
32. Intraocular lymphoma: a clinical perspective.
Davis JL
Eye (Lond); 2013 Feb; 27(2):153-62. PubMed ID: 23196650
[TBL] [Abstract][Full Text] [Related]
33. A comprehensive overview of diagnosis, imaging and treatment of vitreoretinal lymphoma.
Menean M; Giuffrè C; Cicinelli MV; Marchese A; Modorati G; Bandello F; Miserocchi E
Eur J Ophthalmol; 2023 Nov; ():11206721231211931. PubMed ID: 37956540
[TBL] [Abstract][Full Text] [Related]
34. Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphoma.
Motomura Y; Yoshifuji K; Tachibana T; Takase H; Arai A; Tanaka K; Okada K; Nogami A; Umezawa Y; Sakashita C; Yamamoto M; Mori T; Nagao T
Br J Haematol; 2024 Apr; 204(4):1279-1287. PubMed ID: 38131400
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal immunoglobulin heavy chain gene rearrangement in Fuchs' uveitis.
Nakahara H; Kaburaki T; Tanaka R; Matsuda J; Takamoto M; Ohtomo K; Okinaga K; Komae K; Numaga J; Fujino Y; Aihara M
BMC Ophthalmol; 2018 Mar; 18(1):74. PubMed ID: 29523105
[TBL] [Abstract][Full Text] [Related]
36. [Research progress in the diagnosis of primary vitreoretinal lymphoma].
Tuo YR; Zhang MF
Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):954-959. PubMed ID: 37936364
[TBL] [Abstract][Full Text] [Related]
37. Primary Vitreoretinal Lymphoma Therapy Monitoring: Significant Vitreous Haze Reduction After Intravitreal Rituximab.
Kakkassery V; Heindl LM; Rokohl AC; Chronopoulos A; Schutz JS; Ranjbar M; Schargus M; Böker A; Winterhalter S; Stübiger N
Neurosignals; 2021 May; 29(S1):1-7. PubMed ID: 33945240
[TBL] [Abstract][Full Text] [Related]
38. A diagnostic challenge of primary Central nervous system lymphoma: from the eyes to the brain.
Su M; Huang D; Sun L; Dong Z; Wu L; Yu S
Int J Neurosci; 2021 Nov; 131(11):1139-1145. PubMed ID: 32449877
[TBL] [Abstract][Full Text] [Related]
39. Primary central nervous system lymphoma - ocular variant: an interdisciplinary review on management.
Raval V; Binkley E; Aronow ME; Valenzuela J; Peereboom DM; Singh AD
Surv Ophthalmol; 2021; 66(6):1009-1020. PubMed ID: 33762182
[TBL] [Abstract][Full Text] [Related]
40. Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study.
Riemens A; Bromberg J; Touitou V; Sobolewska B; Missotten T; Baarsma S; Hoyng C; Cordero-Coma M; Tomkins-Netzer O; Rozalski A; Tugal-Tutkun I; Guex-Crosier Y; Los LI; Bollemeijer JG; Nolan A; Pawade J; Willermain F; Bodaghi B; ten Dam-van Loon N; Dick A; Zierhut M; Lightman S; Mackensen F; Moulin A; Erckens R; Wensing B; le Hoang P; Lokhorst H; Rothova A
JAMA Ophthalmol; 2015 Feb; 133(2):191-7. PubMed ID: 25412269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
